0001156039-21-000050.txt : 20210526
0001156039-21-000050.hdr.sgml : 20210526
20210526163105
ACCESSION NUMBER: 0001156039-21-000050
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210524
FILED AS OF DATE: 20210526
DATE AS OF CHANGE: 20210526
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gallina John E
CENTRAL INDEX KEY: 0001433032
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-16751
FILM NUMBER: 21966752
MAIL ADDRESS:
STREET 1: 120 MONUMENT CIRCLE
CITY: INDIANAPOLIS
STATE: IN
ZIP: 46204
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Anthem, Inc.
CENTRAL INDEX KEY: 0001156039
STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324]
IRS NUMBER: 352145715
STATE OF INCORPORATION: IN
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 220 VIRGINIA AVENUE
CITY: INDIANAPOLIS
STATE: IN
ZIP: 46204
BUSINESS PHONE: 3174886000
MAIL ADDRESS:
STREET 1: 220 VIRGINIA AVENUE
CITY: INDIANAPOLIS
STATE: IN
ZIP: 46204
FORMER COMPANY:
FORMER CONFORMED NAME: WELLPOINT, INC
DATE OF NAME CHANGE: 20100105
FORMER COMPANY:
FORMER CONFORMED NAME: WELLPOINT INC
DATE OF NAME CHANGE: 20041130
FORMER COMPANY:
FORMER CONFORMED NAME: ANTHEM INC
DATE OF NAME CHANGE: 20010730
4
1
wf-form4_162206103641936.xml
FORM 4
X0306
4
2021-05-24
0
0001156039
Anthem, Inc.
ANTM
0001433032
Gallina John E
220 VIRGINIA AVENUE
INDIANAPOLIS
IN
46204
0
1
0
0
EVP & Chief Financial Officer
Common Stock
2021-05-24
4
M
0
5775
146.93
A
60095
D
Common Stock
2021-05-24
4
M
0
1962
131.80
A
62057
D
Common Stock
2021-05-24
4
M
0
4038
132.51
A
66095
D
Common Stock
2021-05-24
4
M
0
19908
166.97
A
86003
D
Common Stock
2021-05-24
4
M
0
14761
232.04
A
100764
D
Common Stock
2021-05-24
4
S
0
17819
393.56
D
82945
D
Common Stock
2021-05-24
4
S
0
8163
394.62
D
74782
D
Common Stock
2021-05-24
4
S
0
15262
395.67
D
59520
D
Common Stock
2021-05-24
4
S
0
1100
396.50
D
58420
D
Common Stock
2021-05-24
4
S
0
4100
397.91
D
54320
D
Common Stock
2021-05-25
5
G
0
E
3301
0
D
51019
D
Employee Stock Option (Right to Buy)
146.93
2021-05-24
4
M
0
5775
0
D
2025-03-02
Common Stock
5775.0
0
D
Employee Stock Option (Right to Buy)
131.8
2021-05-24
4
M
0
1962
0
D
2026-03-01
Common Stock
1962.0
0
D
Employee Stock Option (Right to Buy)
132.51
2021-05-24
4
M
0
4038
0
D
2026-06-01
Common Stock
4038.0
0
D
Employee Stock Option (Right to Buy)
166.97
2021-05-24
4
M
0
19908
0
D
2027-03-01
Common Stock
19908.0
0
D
Employee Stock Option (Right to Buy)
232.04
2021-05-24
4
M
0
14761
0
D
2028-03-01
Common Stock
14761.0
0
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 22, 2021.
This transaction was executed in multiple trades at prices ranging from $393.17 to $394.16. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $394.18 to $395.17. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $395.23 to $396.17. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $396.23 to $396.56. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $397.50 to $398.39. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
The option represents a right to purchase a total of 5,775 shares and is exercisable in six semi-annual installments, with three installments of 962 shares each and three installments of 963 shares each beginning on September 2, 2015, which is the six-month anniversary of the date on which the option was granted.
The option represents a right to purchase a total of 5,883 shares and is exercisable in six semi-annual installments, with three installments of 980 shares each and three installments of 981 shares each beginning on September 1, 2016, which is the six-month anniversary of the date on which the option was granted.
The option represents a right to purchase a total of 8,074 shares and is exercisable in six semi-annual installments, with two installments of 1,345 shares each and four installments of 1,346 shares each beginning on December 1, 2016, which is the six-month anniversary of the date on which the option was granted.
The option represents a right to purchase a total of 19,908 shares and is exercisable in six semi-annual installments of 3,318 shares each beginning on September 1, 2017, which is the six-month anniversary of the date on which the option was granted.
The option represents a right to purchase a total of 14,761 shares and is exercisable in six semi-annual installments, with five installments of 2,460 shares each and one installment of 2,461 shares beginning on September 1, 2018, which is the six-month anniversary of the date on which the option was granted.
/s/ Kathleen S. Kiefer, Attorney in fact
2021-05-26